What Is HBOT Actually Approved For? UHMS Indications and FDA-Cleared Uses
The recognized indication lists from UHMS and the FDA are shorter than most marketing pages suggest. Here is what each body actually covers, and where the two overlap.
Two different lists, two different meanings
When people ask what hyperbaric oxygen therapy is approved for, they are usually mixing two separate things. One is the list of indications recognized by the Undersea and Hyperbaric Medical Society (UHMS), a professional body whose reference publication is used by clinicians and payers to decide which conditions are considered evidence based and reimbursable. The other is the set of uses that the U.S. Food and Drug Administration has cleared for HBOT devices.
The distinction matters. UHMS recognition reflects a clinical consensus about where the evidence supports treatment. FDA clearance is a regulatory statement that a device may be lawfully marketed for a specific use. A condition can appear on one list, both, or neither, and being sold a chamber says nothing about which uses are supported.
What UHMS recognizes
UHMS maintains a reference titled Hyperbaric Oxygen Therapy Indications, currently in its 14th edition, which the committee updates as evidence changes. Its current list contains roughly 14 recognized indications. These include air or gas embolism, carbon monoxide poisoning, clostridial myonecrosis (gas gangrene), crush injury and other acute traumatic ischemias, decompression sickness, selected problem wounds such as diabetic foot ulcers, severe anemia where transfusion is not possible, intracranial abscess, necrotizing soft tissue infections, refractory osteomyelitis, delayed radiation injury, compromised grafts and flaps, acute thermal burns, and idiopathic sudden sensorineural hearing loss, which the board added in 2011.
Most of these are either acute emergencies that require immediate treatment or specific chronic conditions that have been studied in a hospital setting. The list is deliberately narrow, and UHMS does not recognize the broad wellness and anti-aging uses that appear in consumer advertising.
What the FDA has cleared
In its consumer update Hyperbaric Oxygen Therapy: Get the Facts, the FDA lists the conditions for which it has cleared HBOT devices. These cover air and gas bubbles in blood vessels, severe anemia, burns, carbon monoxide poisoning, crush injury, decompression sickness from diving, gas gangrene, certain types of sudden hearing loss, severe skin and bone infections, radiation injury, a skin graft or flap at risk of tissue death, certain types of sudden painless vision loss from blocked blood flow, and non-healing wounds including diabetic foot ulcers.
The FDA also states plainly what is not cleared. It has warned that some centers promote chambers for conditions such as cancer, Lyme disease, autism, and Alzheimer disease, for which HBOT is not cleared or approved. HBOT devices are regulated as Class II medical devices, generally cleared through the 510(k) pathway.
Why buyers should read past the marketing list
A recurring problem for anyone comparing equipment is that vendor pages often present a long list of treatable conditions that far exceeds what either UHMS or the FDA recognizes. A useful habit is to check any claimed use against the two lists above and to treat anything outside them as off-label or investigational, regardless of how confidently it is presented.
It also helps to separate the device from the indication. Learning how different systems are built and pressurized, for example by reading a neutral overview at HBOT chambers, is a different question from whether your specific condition is one that recognized bodies support treating. The equipment can be perfectly legitimate while the advertised use is not.
None of the above is a diagnosis or a treatment plan. Whether a recognized indication applies to a particular person is a clinical judgment, and that conversation belongs with a qualified physician rather than with a sales page.